// App-Quantinova.ai

3108 : PD-L1 expressing circulating tumor cells (CTCs) in patients with head and neck squamous cell carcinoma (HNSCC)

Researchers

Presenter

  • Areti Strati

Principal Investigators

  • George Koutsodontis

  • Ilias Angelidis

  • Clarence Sasaki

  • Margaritis Avgeris

  • Amanda Psyrri

  • Evi S. Lianidou

Medical Centers

  • Analysis of Circulating Tumor Cells Laboratory, Dept of Chemistry, Univ. of Athens, Athens, Greece

  • Oncology Unit, nd Department of Internal Medicine - Propaedeutic, Attikon University Hospital, Haidari, Greece, Athens, Greece

  • Department of Surgery, Section of Otolaryngology, Yale University School of Medicine, New Haven, CT

  • Dept of Biology, Univ. of Athens, Athens, Greece.

Locations

  • United States

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Squamous cell carcinoma of the head and neck

Biomarkers

  • Circulating tumor cells

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved